Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
Elanco Animal Health (NYSE:ELAN) announced its participation in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference, scheduled for September 8-9, 2025. The company's leadership, including President and CEO Jeff Simmons and EVP and CFO Bob VanHimbergen, will engage in a fireside chat on September 9 at 8:30 a.m. ET.
Investors can access a live audio webcast through the "Events and Presentations" section of Elanco's investor website, with a replay available for a limited time after the event.
Elanco Animal Health (NYSE:ELAN) ha annunciato la propria partecipazione alla Morgan Stanley 23rd Annual Global Healthcare Conference, in programma l'8 e il 9 settembre 2025. La direzione della società, tra cui il President and CEO Jeff Simmons e il EVP and CFO Bob VanHimbergen, sarà protagonista di un fireside chat il 9 settembre alle 8:30 ET.
Gli investitori potranno seguire la trasmissione audio in diretta tramite la sezione "Events and Presentations" del sito investor di Elanco; la registrazione sarà disponibile per la visione on demand per un periodo limitato dopo l'evento.
Elanco Animal Health (NYSE:ELAN) anunció su participación en la Morgan Stanley 23rd Annual Global Healthcare Conference, programada para los días 8 y 9 de septiembre de 2025. La dirección de la compañía, incluidos el President and CEO Jeff Simmons y el EVP and CFO Bob VanHimbergen, participará en un fireside chat el 9 de septiembre a las 8:30 a.m. ET.
Los inversores podrán acceder a la retransmisión de audio en vivo a través de la sección "Events and Presentations" del sitio de inversores de Elanco; la repetición estará disponible por tiempo limitado después del evento.
Elanco Animal Health (NYSE:ELAN)는 2025년 9월 8~9일에 개최되는 Morgan Stanley 제23회 연례 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. President and CEO Jeff Simmons 및 EVP and CFO Bob VanHimbergen를 포함한 경영진이 9월 9일 오전 8시 30분(동부 시간)에 파이어사이드 채팅에 참여합니다.
투자자들은 Elanco 투자자 웹사이트의 "Events and Presentations" 섹션을 통해 실시간 오디오 웹캐스트를 청취할 수 있으며, 행사 후 제한된 기간 동안 다시보기 이용이 가능합니다.
Elanco Animal Health (NYSE:ELAN) a annoncé sa participation à la Morgan Stanley 23rd Annual Global Healthcare Conference, prévue les 8 et 9 septembre 2025. La direction de l'entreprise, notamment le President and CEO Jeff Simmons et le EVP and CFO Bob VanHimbergen, participera à un fireside chat le 9 septembre à 8h30 ET.
Les investisseurs pourront accéder à la diffusion audio en direct via la rubrique "Events and Presentations" du site investisseurs d'Elanco ; une rediffusion sera disponible pendant une durée limitée après l'événement.
Elanco Animal Health (NYSE:ELAN) gab seine Teilnahme an der Morgan Stanley 23rd Annual Global Healthcare Conference bekannt, die für den 8. und 9. September 2025 geplant ist. Die Unternehmensführung, darunter President and CEO Jeff Simmons und EVP and CFO Bob VanHimbergen, wird am 9. September um 8:30 Uhr ET an einem Fireside-Chat teilnehmen.
Investoren können den Live-Audio-Webcast über den Bereich "Events and Presentations" auf Elancos Investorenseite verfolgen; eine Aufzeichnung steht nach der Veranstaltung für eine begrenzte Zeit zur Verfügung.
- None.
- None.
A live audio webcast will be available in the "Events and Presentations" section of Elanco's investor website. A replay will be available for a limited time at the conclusion of the event.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. Learn more at www.elanco.com.
Investor Contact: Tiffany Kanaga (765) 740-0314 tiffany.kanaga@elancoah.com
Media Contact: Colleen Parr Dekker (317) 989-7011 colleen.dekker@elancoah.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/elanco-to-participate-in-morgan-stanley-23rd-annual-global-healthcare-conference-302538103.html
SOURCE Elanco Animal Health
FAQ
When is Elanco (NYSE:ELAN) presenting at the Morgan Stanley Healthcare Conference 2025?
Who will represent Elanco at the Morgan Stanley Healthcare Conference 2025?
How can investors access Elanco's Morgan Stanley conference presentation?
What is the duration of the Morgan Stanley Healthcare Conference 2025?
